title: Dose verification of eye plaque brachytherapy using spectroscopic dosimetry.
abstract: Eye plaque brachytherapy has been developed and refined for the last 80 years, demonstrating effective results in the treatment of ocular malignancies. Current dosimetry techniques for eye plaque brachytherapy (such as TLD- and film-based techniques) are time consuming and cannot be used prior to treatment in a sterile environment. The measurement of the expected dose distribution within the eye, prior to insertion within the clinical setting, would be advantageous, as any errors in source loading will lead to an erroneous dose distribution and inferior treatment outcomes. This study investigated the use of spectroscopic dosimetry techniques for real-time quality assurance of I-125 based eye plaques, immediately prior to insertion. A silicon detector based probe, operating in spectroscopy mode was constructed, containing a small (1 mm(3)) silicon detector, mounted within a ceramic holder, all encapsulated within a rubber sheath to prevent water infiltration of the electronics. Preliminary tests of the prototype demonstrated that the depth dose distribution through the central axis of an I-125 based eye plaque may be determined from AAPM Task Group 43 recommendations to a deviation of 6 % at 3 mm depth, 7 % at 5 mm depth, 1 % at 10 mm depth and 13 % at 20 mm depth, with the deviations attributed to the construction of the probe. A new probe design aims to reduce these discrepancies, however the concept of spectroscopic dosimetry shows great promise for use in eye plaque quality assurance in the clinical setting.
authors.affiliation: Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia. talia.jarema@roc.team.|Radiation Oncology Centres, Toowoomba, QLD, Australia. talia.jarema@roc.team.
authors.forename: T
authors.initials: T
authors.lastname: Jarema
authors.affiliation: Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Cutajar
authors.affiliation: Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Weaver
authors.affiliation: Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Petasecca
authors.affiliation: Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Lerch
authors.affiliation: Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Kejda
authors.affiliation: Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Rosenfeld
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D002138:Calibration; D004307:Dose-Response Relationship, Radiation; D005123:Eye / Q000528:radiation effects*; D006801:Humans; D011874:Radiometry; D015203:Reproducibility of Results; D013057:Spectrum Analysis; D014965:X-Rays
keywords: Dose verification; Eye plaque brachytherapy; Spectroscopic dosimetry